Karriereverlauf von Lynn Gallant
Ehemalige bekannte Positionen von Lynn Gallant
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 22.02.2023 | 01.05.2023 |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Lynn Gallant
| University of New England | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Kanada | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- Lynn Gallant
- Erfahrung
